1. Home
  2. PULM vs AWRE Comparison

PULM vs AWRE Comparison

Compare PULM & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • AWRE
  • Stock Information
  • Founded
  • PULM 2003
  • AWRE 1986
  • Country
  • PULM United States
  • AWRE United States
  • Employees
  • PULM N/A
  • AWRE N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • AWRE Computer Software: Prepackaged Software
  • Sector
  • PULM Health Care
  • AWRE Technology
  • Exchange
  • PULM Nasdaq
  • AWRE Nasdaq
  • Market Cap
  • PULM 33.2M
  • AWRE 34.6M
  • IPO Year
  • PULM N/A
  • AWRE 1996
  • Fundamental
  • Price
  • PULM $6.94
  • AWRE $1.83
  • Analyst Decision
  • PULM
  • AWRE
  • Analyst Count
  • PULM 0
  • AWRE 0
  • Target Price
  • PULM N/A
  • AWRE N/A
  • AVG Volume (30 Days)
  • PULM 62.8K
  • AWRE 50.0K
  • Earning Date
  • PULM 08-12-2025
  • AWRE 08-07-2025
  • Dividend Yield
  • PULM N/A
  • AWRE N/A
  • EPS Growth
  • PULM N/A
  • AWRE N/A
  • EPS
  • PULM N/A
  • AWRE N/A
  • Revenue
  • PULM $1,921,000.00
  • AWRE $16,576,000.00
  • Revenue This Year
  • PULM N/A
  • AWRE N/A
  • Revenue Next Year
  • PULM $134.88
  • AWRE N/A
  • P/E Ratio
  • PULM N/A
  • AWRE N/A
  • Revenue Growth
  • PULM N/A
  • AWRE N/A
  • 52 Week Low
  • PULM $1.78
  • AWRE $1.35
  • 52 Week High
  • PULM $10.40
  • AWRE $2.97
  • Technical
  • Relative Strength Index (RSI)
  • PULM 42.62
  • AWRE 63.37
  • Support Level
  • PULM $6.36
  • AWRE $1.69
  • Resistance Level
  • PULM $7.99
  • AWRE $2.30
  • Average True Range (ATR)
  • PULM 0.90
  • AWRE 0.14
  • MACD
  • PULM -0.24
  • AWRE 0.01
  • Stochastic Oscillator
  • PULM 50.16
  • AWRE 38.57

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

Share on Social Networks: